Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3523679012 | Product containing certolizumab pegol (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3713866015 | Certolizumab pegol-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing certolizumab pegol (medicinal product) | Is a | Inflammatory bowel disease drug | false | Inferred relationship | Some | ||
| Product containing certolizumab pegol (medicinal product) | Is a | Product containing monoclonal antibody (product) | true | Inferred relationship | Some | ||
| Product containing certolizumab pegol (medicinal product) | Has active ingredient | Certolizumab pegol (substance) | true | Inferred relationship | Some | 1 | |
| Product containing certolizumab pegol (medicinal product) | Is a | Product containing tumor necrosis factor alpha inhibitor (product) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Certolizumab pegol 200mg powder for injection solution vial + diluent | Is a | False | Product containing certolizumab pegol (medicinal product) | Inferred relationship | Some | |
| Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | False | Product containing certolizumab pegol (medicinal product) | Inferred relationship | Some | |
| Product containing only certolizumab pegol (medicinal product) | Is a | True | Product containing certolizumab pegol (medicinal product) | Inferred relationship | Some | |
| Product containing certolizumab pegol in parenteral dose form (medicinal product form) | Is a | True | Product containing certolizumab pegol (medicinal product) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR